Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart Failure
Clinical trial NCT05566600 · UNKNOWN
Trial details
- NCT number
- NCT05566600
- Sponsor
- HELP Therapeutics Co., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-09
- Primary completion
- 2024-12-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.